Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
Aspire Biopharma Holdings (NASDAQ:ASBP), a company developing patent-pending drug and supplement delivery technology, has announced its participation in the upcoming Sidoti Virtual Investor Conference. Interim CEO Kraig Higginson will present on August 20, 2025, at 1:45 PM Eastern.
The company will also host one-on-one meetings with investors on August 20-21, 2025. Investors can access the virtual presentation through Sidoti's registration platform, and a replay will be available on Aspire's investor relations website.
Aspire Biopharma Holdings (NASDAQ:ASBP), una societ脿 che sviluppa una tecnologia in attesa di brevetto per la somministrazione di farmaci e integratori, ha annunciato la propria partecipazione alla prossima Sidoti Virtual Investor Conference. Il CEO ad interim Kraig Higginson presenter脿 il 20 agosto 2025 alle 13:45 (ora Eastern).
La societ脿 terr脿 inoltre incontri individuali con gli investitori il 20-21 agosto 2025. Gli investitori potranno accedere alla presentazione virtuale tramite la piattaforma di registrazione di Sidoti e la replica sar脿 disponibile sul sito delle relazioni con gli investitori di Aspire.
Aspire Biopharma Holdings (NASDAQ:ASBP), una empresa que desarrolla una tecnolog铆a de entrega de f谩rmacos y suplementos con patente en tr谩mite, ha anunciado su participaci贸n en la pr贸xima Sidoti Virtual Investor Conference. El CEO interino Kraig Higginson presentar谩 el 20 de agosto de 2025 a la 1:45 p.m., hora del Este.
La compa帽铆a tambi茅n mantendr谩 reuniones individuales con inversores el 20 y 21 de agosto de 2025. Los inversores podr谩n acceder a la presentaci贸n virtual a trav茅s de la plataforma de registro de Sidoti, y la repetici贸n estar谩 disponible en el sitio web de relaciones con inversores de Aspire.
Aspire Biopharma Holdings (NASDAQ:ASBP)電� 鞚橃暯頀� 氚� 氤挫订鞝� 鞝勲嫭鞚� 鞙勴暅 韸鬼棃 於滌洂 欷戩澑 旮办垹鞚� 臧滊皽頃橂姅 須岇偓搿�, 雼り岸撵槫電� Sidoti Virtual Investor Conference鞐� 彀戈岸捻暅雼り碃 氚滍憸頄堨姷雼堧嫟. 鞛勳嫓 CEO Kraig Higginson臧赌 2025雲� 8鞗� 20鞚� 鞓ろ泟 1鞁� 45攵�(氙戈淡 霃欕秬 鞁滉皠)鞐� 氚滍憸頃╇媹雼�.
須岇偓電� 霕愴暅 2025雲� 8鞗� 20~21鞚� 韴瀽鞛愳檧鞚� 鞚茧寑鞚� 氙疙寘霃� 歆勴枆頃╇媹雼�. 韴瀽鞛愲摛鞚� Sidoti鞚� 霌彪 頂岆灚韽检潉 韱淀暣 臧赌靸� 頂勲爤鞝犿厡鞚挫厴鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 雼れ嫓氤搓赴電� Aspire鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅╇媹雼�.
Aspire Biopharma Holdings (NASDAQ:ASBP), une soci茅t茅 d茅veloppant une technologie de d茅livrance de m茅dicaments et de compl茅ments en instance de brevet, a annonc茅 sa participation 脿 la prochaine Sidoti Virtual Investor Conference. Le PDG par int茅rim Kraig Higginson pr茅sentera le 20 ao没t 2025 脿 13h45, heure de l'Est.
La soci茅t茅 organisera 茅galement des r茅unions individuelles avec des investisseurs les 20 et 21 ao没t 2025. Les investisseurs pourront acc茅der 脿 la pr茅sentation virtuelle via la plateforme d'inscription de Sidoti, et une rediffusion sera disponible sur le site des relations investisseurs d'Aspire.
Aspire Biopharma Holdings (NASDAQ:ASBP), ein Unternehmen, das eine zum Patent angemeldete Technologie zur Verabreichung von Medikamenten und Nahrungserg盲nzungsmitteln entwickelt, hat seine Teilnahme an der bevorstehenden Sidoti Virtual Investor Conference angek眉ndigt. Interims-CEO Kraig Higginson wird am 20. August 2025 um 13:45 Uhr (Eastern Time) 辫谤盲蝉别苍迟颈别谤别苍.
Das Unternehmen wird au脽erdem Einzelgespr盲che mit Investoren am 20. und 21. August 2025 f眉hren. Investoren k枚nnen die virtuelle Pr盲sentation 眉ber die Registrierungsplattform von Sidoti aufrufen; eine Aufzeichnung wird auf der Investor-Relations-Website von Aspire verf眉gbar sein.
- None.
- None.
ESTERO, FL / / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here:
One-on-One Meetings
Aspire will also host virtual one-on-ones with investors on Wednesday, August 20 and Thursday, August 21, 2025. To register for the presentation or one-on ones, visit .
A replay of the presentation will be available on the investor relations section of Aspire's website at
About Aspire Biopharma, Inc.
Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit .
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original on ACCESS Newswire
FAQ
When is Aspire Biopharma (NASDAQ:ASBP) presenting at the Sidoti Virtual Investor Conference?
Who will be presenting for Aspire Biopharma at the Sidoti Conference?
How can investors access Aspire Biopharma's Sidoti Conference presentation?
What dates will Aspire Biopharma host one-on-one investor meetings?
